$ARVN mention timeline

Arvinas. Every tracked FinTwit mention of $ARVN, newest first. 16 mentions since the first on Jun 19, 2025. See the price chart.

May 2026 · 5 mentions

May 12
Adam Feuerstein ✡️ — $RIGL will sell the newly approved Veppanu for $ARVN and $PFE. Modest financial terms https://t.co/9RsbSMzxBf↗
May 1
Adam Feuerstein ✡️ — $ARVN statement: "We are especially encouraged by receiving FDA approval ahead of the June 5 PDUFA date and together with Pfizer, we are on track to announce selection of a third p…↗
May 1
Adam Feuerstein ✡️ — FDA approves vepdegrestrant one month early. $ARVN and $PFE still haven't found (or disclosed) a third-party company to commercialize it. What a world...↗
May 1
Jacob Plieth — Just to rub salt into $AZN's wounds then. $ARVN https://t.co/kivCygY5ZL↗
May 1
Adam Feuerstein ✡️ — $ARVN FDA approval https://t.co/o22KYPe5v3↗

Feb 20
Jacob Plieth — We know $ARVN is no different, and I doubt $OLMA will be. You can game a trial, but you can't really circumvent basic science $AZN $RHHBY $LLY↗

Dec 12
Jacob Plieth — Shock! $LLY reveals Inluriyo + Verzenio combo filing in ESR1m only, despite showing #SABCS25 promise in ESR1w/t. Scoop via @ApexOnco -> https://t.co/gUDeeMpmXb $RHHBY $AZN $ARVN…↗

Nov 17
Jacob Plieth — Halda turns $202m into $3bn from $JNJ (plus a #sadtrombone for $ARVN). Via @ApexOnco -> https://t.co/7zXwDOTMS6↗
Nov 17
Jacob Plieth — Who knew?! $ARVN $JNJ↗

Sep 17
Adam Feuerstein ✡️ — I feel bad for the person who had to write the $ARVN press release. "You want us to say... what, exactly?"↗
Sep 17
Jacob Plieth — Surprising outcome $ARVN $PFE https://t.co/zCOiKsNH01↗

Jul 9
Jacob Plieth — His parting shot appears to have been: we hate $PFE https://t.co/WVZqAtK8cE $ARVN↗
Jul 3
Jacob Plieth — Obvious assumption is that the $PFE deal is effectively dead (though officially it limps on). Next Q: how much will it cost $ARVN to buy back the vepdegestrant data $PFE generated…↗
Jul 3
Jacob Plieth — LOL, $ARVN CEO John Houston, speaking at Jefferies 1 mth after I sent that tweet: "Not as much value as we originally thought. Seeing if we can change the collaboration. If $PFE do…↗

Jun 30
Jacob Plieth — You already have a small-molecule inhibitor, so do you also need a degrader? $ONC $BGNE thinks yes, for BTK, CDK2 & Kras. Via @ApexOnco -> https://t.co/LFJCsl1MQj $ARVN $GIL…↗
Jun 19
Jacob Plieth — $ARVN into phase 1 with a Kras G12D degrader, ARV-806. Let's hope it's better than $ALPMF ASP3082! https://t.co/b55st9i1yh↗